These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35676709)

  • 1. Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study.
    Guler SA; Machahua C; Geiser TK; Kocher G; Marti TM; Tan B; Trappetti V; Ryerson CJ; Funke-Chambour M
    Respir Res; 2022 Jun; 23(1):149. PubMed ID: 35676709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival.
    Keow J; Cecchini MJ; Jayawardena N; Zompatori M; Joseph MG; Mura M
    Respir Res; 2022 Jun; 23(1):147. PubMed ID: 35672770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosis.
    Mendoza-Milla C; Valero Jiménez A; Rangel C; Lozano A; Morales V; Becerril C; Chavira R; Ruiz V; Barrera L; Montaño M; Pardo A; Selman M
    Eur Respir J; 2013 Nov; 42(5):1309-21. PubMed ID: 23143540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).
    Joannes A; Voisin T; Morzadec C; Letellier A; Gutierrez FL; Chiforeanu DC; Le Naoures C; Guillot S; De Latour BR; Rouze S; Jaillet M; Crestani B; Wollin L; Jouneau S; Vernhet L
    Pulm Pharmacol Ther; 2023 Dec; 83():102267. PubMed ID: 37972706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
    Tsitoura E; Trachalaki A; Vasarmidi E; Mastrodemou S; Margaritopoulos GA; Kokosi M; Fanidis D; Galaris A; Aidinis V; Renzoni E; Tzanakis N; Wells AU; Antoniou KM
    Front Immunol; 2021; 12():645548. PubMed ID: 34867934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clubbing in patients with fibrotic interstitial lung diseases.
    van Manen MJG; Vermeer LC; Moor CC; Vrijenhoeff R; Grutters JC; Veltkamp M; Wijsenbeek MS
    Respir Med; 2017 Nov; 132():226-231. PubMed ID: 29229102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease.
    Isshiki T; Vierhout M; Naiel S; Ali P; Yazdanshenas P; Kumaran V; Yang Z; Dvorkin-Gheva A; Rullo AF; Kolb MRJ; Ask K
    Biochem Pharmacol; 2023 May; 211():115501. PubMed ID: 36921632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus.
    Zhang X; Xiao J; Liu T; He Q; Cui J; Tang S; Li X; Liu M
    Front Endocrinol (Lausanne); 2022; 13():890029. PubMed ID: 35832423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices.
    Alsafadi HN; Staab-Weijnitz CA; Lehmann M; Lindner M; Peschel B; Königshoff M; Wagner DE
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L896-L902. PubMed ID: 28314802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Lung Biopsy Information on Treatment Strategy of Patients with Interstitial Lung Diseases.
    Tomassetti S; Ravaglia C; Puglisi S; Ryu JH; Colby TV; Cavazza A; Wells AU; Pavone M; Vancheri C; Lavorini F; Matucci-Cerinic M; Rosi E; Luzzi V; Gori L; Rossi G; Donati L; Dubini A; Piciucchi S; Poletti V
    Ann Am Thorac Soc; 2022 May; 19(5):737-745. PubMed ID: 34739359
    [No Abstract]   [Full Text] [Related]  

  • 14. Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Joannes A; Morzadec C; Duclos M; Gutierrez FL; Chiforeanu DC; Le Naoures C; De Latour B; Rouzé S; Wollin L; Jouneau S; Vernhet L
    Toxicol Appl Pharmacol; 2022 Apr; 441():115972. PubMed ID: 35276128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Voisin T; Joannes A; Morzadec C; Lagadic-Gossmann D; Naoures CL; De Latour BR; Rouze S; Jouneau S; Vernhet L
    J Nutr Biochem; 2024 Mar; 125():109558. PubMed ID: 38185349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length across different UIP fibrotic-Interstitial Lung Diseases: a prospective Greek case-control study.
    Tomos I; Karakatsani A; Manali ED; Kottaridi C; Spathis A; Argentos S; Papiris SA
    Pulmonology; 2022; 28(4):254-261. PubMed ID: 33358512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
    Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
    Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
    Collins BF; Luppi F
    Clin Chest Med; 2021 Jun; 42(2):321-335. PubMed ID: 34024407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
    Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
    Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
    Zhang J; Wang D; Wang L; Wang S; Roden AC; Zhao H; Li X; Prakash YS; Matteson EL; Tschumperlin DJ; Vassallo R
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L487-L497. PubMed ID: 30604628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.